Patent · US Active

Vascular endothelial receptor specific inhibitors

US7939557B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2007
Grant dateMay 10, 2011
Priority date
Expiry dateAug 19, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application describes isoindoles and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful inhibitors of VEGFR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.